Kotaro Hirashima
YOU?
Author Swipe
View article: Data from SPINK1 Status in Colorectal Cancer, Impact on Proliferation, and Role in Colitis-Associated Cancer
Data from SPINK1 Status in Colorectal Cancer, Impact on Proliferation, and Role in Colitis-Associated Cancer Open
Colorectal cancer is a major cause of deaths due to cancer; therefore, research into its etiology is urgently needed. Although it is clear that chronic inflammation is a risk factor for colorectal cancer, the details remain uncertain. Seri…
View article: Supplemental Figure 1 from SPINK1 Status in Colorectal Cancer, Impact on Proliferation, and Role in Colitis-Associated Cancer
Supplemental Figure 1 from SPINK1 Status in Colorectal Cancer, Impact on Proliferation, and Role in Colitis-Associated Cancer Open
Supplemental Figure 1. Survival curves of SPINK1 expression in colorectal cancer patients. Black bar indicates high SPINK1 expression and gray bar indicates low SPINK1 expression.
View article: Data from SPINK1 Status in Colorectal Cancer, Impact on Proliferation, and Role in Colitis-Associated Cancer
Data from SPINK1 Status in Colorectal Cancer, Impact on Proliferation, and Role in Colitis-Associated Cancer Open
Colorectal cancer is a major cause of deaths due to cancer; therefore, research into its etiology is urgently needed. Although it is clear that chronic inflammation is a risk factor for colorectal cancer, the details remain uncertain. Seri…
View article: Supplemental Figure 1 from SPINK1 Status in Colorectal Cancer, Impact on Proliferation, and Role in Colitis-Associated Cancer
Supplemental Figure 1 from SPINK1 Status in Colorectal Cancer, Impact on Proliferation, and Role in Colitis-Associated Cancer Open
Supplemental Figure 1. Survival curves of SPINK1 expression in colorectal cancer patients. Black bar indicates high SPINK1 expression and gray bar indicates low SPINK1 expression.
View article: Data from Small Molecule Agonists of PPAR-γ Exert Therapeutic Effects in Esophageal Cancer
Data from Small Molecule Agonists of PPAR-γ Exert Therapeutic Effects in Esophageal Cancer Open
The transcription factor PPAR-γ plays various roles in lipid metabolism, inflammation, cellular differentiation, and apoptosis. PPAR-γ agonists used to treat diabetes may have utility in cancer treatment. Efatutazone is a novel later gener…
View article: Supplementary Table 1 from Small Molecule Agonists of PPAR-γ Exert Therapeutic Effects in Esophageal Cancer
Supplementary Table 1 from Small Molecule Agonists of PPAR-γ Exert Therapeutic Effects in Esophageal Cancer Open
PDF file - 120K, Clinical or pathological feature according to PPARγ expression.
View article: Supplementary Methods from Small Molecule Agonists of PPAR-γ Exert Therapeutic Effects in Esophageal Cancer
Supplementary Methods from Small Molecule Agonists of PPAR-γ Exert Therapeutic Effects in Esophageal Cancer Open
PDF file - 165K
View article: Supplementary Table 2 from Small Molecule Agonists of PPAR-γ Exert Therapeutic Effects in Esophageal Cancer
Supplementary Table 2 from Small Molecule Agonists of PPAR-γ Exert Therapeutic Effects in Esophageal Cancer Open
PDF file - 112K, PPARγ status in ESCC and patient mortality.
View article: Supplementary Figure Legend from Small Molecule Agonists of PPAR-γ Exert Therapeutic Effects in Esophageal Cancer
Supplementary Figure Legend from Small Molecule Agonists of PPAR-γ Exert Therapeutic Effects in Esophageal Cancer Open
PDF file - 107K
View article: Supplementary Table 1 from Small Molecule Agonists of PPAR-γ Exert Therapeutic Effects in Esophageal Cancer
Supplementary Table 1 from Small Molecule Agonists of PPAR-γ Exert Therapeutic Effects in Esophageal Cancer Open
PDF file - 120K, Clinical or pathological feature according to PPARγ expression.
View article: Supplementary Figures 1 - 9 from Small Molecule Agonists of PPAR-γ Exert Therapeutic Effects in Esophageal Cancer
Supplementary Figures 1 - 9 from Small Molecule Agonists of PPAR-γ Exert Therapeutic Effects in Esophageal Cancer Open
PDF file - 818K, The study design for selecting the ESCC patients (S1); TE-4 cells were transfected with PPARG siRNA (S2); In vitro anti-proliferative effects of efatutazone (S3); Anti-proliferative effects of efatutazone in ESCC cells occ…
View article: Supplementary Table 2 from Small Molecule Agonists of PPAR-γ Exert Therapeutic Effects in Esophageal Cancer
Supplementary Table 2 from Small Molecule Agonists of PPAR-γ Exert Therapeutic Effects in Esophageal Cancer Open
PDF file - 112K, PPARγ status in ESCC and patient mortality.
View article: Supplementary Figures 1 - 9 from Small Molecule Agonists of PPAR-γ Exert Therapeutic Effects in Esophageal Cancer
Supplementary Figures 1 - 9 from Small Molecule Agonists of PPAR-γ Exert Therapeutic Effects in Esophageal Cancer Open
PDF file - 818K, The study design for selecting the ESCC patients (S1); TE-4 cells were transfected with PPARG siRNA (S2); In vitro anti-proliferative effects of efatutazone (S3); Anti-proliferative effects of efatutazone in ESCC cells occ…
View article: Supplementary Figure Legend from Small Molecule Agonists of PPAR-γ Exert Therapeutic Effects in Esophageal Cancer
Supplementary Figure Legend from Small Molecule Agonists of PPAR-γ Exert Therapeutic Effects in Esophageal Cancer Open
PDF file - 107K
View article: Supplementary Methods from Small Molecule Agonists of PPAR-γ Exert Therapeutic Effects in Esophageal Cancer
Supplementary Methods from Small Molecule Agonists of PPAR-γ Exert Therapeutic Effects in Esophageal Cancer Open
PDF file - 165K
View article: Data from Small Molecule Agonists of PPAR-γ Exert Therapeutic Effects in Esophageal Cancer
Data from Small Molecule Agonists of PPAR-γ Exert Therapeutic Effects in Esophageal Cancer Open
The transcription factor PPAR-γ plays various roles in lipid metabolism, inflammation, cellular differentiation, and apoptosis. PPAR-γ agonists used to treat diabetes may have utility in cancer treatment. Efatutazone is a novel later gener…
View article: Strangulation of the small intestine caused by an intra-mesosigmoid hernia: a case report
Strangulation of the small intestine caused by an intra-mesosigmoid hernia: a case report Open
Sigmoid mesocolon hernia is an uncommon type of internal hernia with only a few cases reported to date. This disease entity can progress rapidly to cause vascular disturbance, necrosis, and perforation of the bowel wall; therefore, early d…
View article: Benign esophageal schwannoma: a brief overview and our experience with this rare tumor
Benign esophageal schwannoma: a brief overview and our experience with this rare tumor Open
We report our experience with esophageal schwannoma, a rare but benign diagnosis of the esophagus.
View article: Internal hernia after laparoscopic-assisted proximal gastrectomy with jejunal interposition for gastric cancer: a case report
Internal hernia after laparoscopic-assisted proximal gastrectomy with jejunal interposition for gastric cancer: a case report Open